First-line treatment of women with advanced ovarian cancer: focus on bevacizumab

First-line treatment of women with advanced ovarian cancer: focus on bevacizumab

Claudia Marchetti, Ludovico Muzii, Alessia Romito, Pierluigi Benedetti Panici Department of Gynecological-Obstetrical and Urological Sciences, Sapienza University of Rome, Rome, Italy Abstract: Ovarian cancer is the fifth most common cause of cancer death in women in Europe. Despite the progress,...

Full description

Bibliographic Details
Main Authors: Marchetti C, Muzii L, Romito A, Benedetti Panici P
Format: Article
Language:English
Published: Dove Medical Press 2019-02-01
Series:OncoTargets and Therapy
Subjects:
ovarian cancer
first-line treatment
bevacizumab
anti-angiogenesis
Online Access:https://www.dovepress.com/first-line-treatment-of-women-with-advanced-ovarian-cancer-focus-on-be-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/first-line-treatment-of-women-with-advanced-ovarian-cancer-focus-on-be-peer-reviewed-article-OTT

Similar Items